Back
Neurocrine Biosciences Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
41
NBIX
Neurocrine Biosciences
Last Price:
120.45
Seasonality Move:
9.9%
Sell
42
LBPH
Longboard Pharmaceuticals
Last Price:
33.39
Seasonality Move:
-17.05%
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $119.85. The Score for NBIX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NBIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Longboard Pharmaceuticals (LBPH)
is a Sell
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $29.31. The Score for LBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $119.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $29.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.27 | Sell |
Relative Strength Index (14 RSI): | 30.83 | Sell |
Chaikin Money Flow: | -802737 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.06 | Sell |
Relative Strength Index (14 RSI): | 38.7 | Sell |
Chaikin Money Flow: | 434120 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NBIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.15 | Sell |
20-day SMA: | 129.92 | Sell |
50-day SMA: | 139.98 | Sell |
200-day SMA: | 136.32 | Sell |
8-day EMA: | 122.12 | Sell |
20-day EMA: | 127.93 | Sell |
50-day EMA: | 134.98 | Sell |
200-day EMA: | 133.19 | Sell |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.33 | Sell |
20-day SMA: | 34.08 | Sell |
50-day SMA: | 34.97 | Sell |
200-day SMA: | 23.09 | Buy |
8-day EMA: | 31.57 | Sell |
20-day EMA: | 33.23 | Sell |
50-day EMA: | 32.69 | Sell |
200-day EMA: | 24.04 | Buy |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Neurocrine Biosciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |